Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads.
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.
[Resistance to protease inhibitors].
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.